IP Library › Assignment 048590/0059
Patent Assignment
Reel/Frame 048590/0059

Assignment of Assignor's Interest

Recorded: 2019-03-13 Pages: 16
Assignor
Assignee
THE SCRIPPS RESEARCH INSTITUTE
10550 NORTH TORREY PINES ROAD, LA JOLLA, CALIFORNIA, 92037
Covered Properties (97)
Compounds for Treatment of Drug Resistant and Persistent Tuberculosis
Application: 61/827,539 →
Compounds for Treatment of Drug Resistant and Persistent Tuberculosis
Application: 61/950,752 →
Bovine Fusion Antibodies
Application: 61/751,598 →
Bovine Fusion Antibodies
Patent: 9,644,021 →
Application: 14/152,441 →
Publication: US 2014/0227267
Bispecific Antibodies and Uses Thereof
Application: 61/783,426 →
Bispecific Antibodies and Uses Thereof
Application: 61/839,330 →
Targeting Agent Antibody Conjugates and Uses Thereof
Application: 15/268,389 →
Publication: US 2017/0002076
Compounds and Methods for Inducing Chondrogenesis
Application: 61/794,094 →
Compounds and Methods for Inducing Chondrogenesis
Patent: 9,452,170 →
Application: 14/210,198 →
Publication: US 2014/0271955
Small Molecule Inhibitors of Fibrosis
Application: 61/832,768 →
Small Molecule Inhibitors of Fibrosis
Patent: 9,981,956 →
Application: 15/488,206 →
Publication: US 2017/0217943
Methods of Producing Switchable Chimeric Antigen Receptor T Cells and Uses Thereof
Application: 61/891,347 →
Methods of Producing Switchable Chimeric Antigen Receptor T Cells and Uses Thereof
Application: 61/895,704 →
Chimeric Antigen Receptor T Cell Switches and Uses Thereof
Application: 62/009,056 →
Chimeric Antigen Receptor T Cell Switches and Uses Thereof
Application: 15/363,350 →
Chimeric Antigen Receptor T Cell Switches and Uses Thereof
Application: 15/644,657 →
Publication: US 2018/0104354
Peptidic Chimeric Antigen Receptor T Cell Switches and Uses Thereof
Patent: 9,624,276 →
Application: 14/688,894 →
Publication: US 2015/0307564
Peptidic Chimeric Antigen Receptor T Cell Switches and Uses Thereof
Application: 15/448,477 →
Publication: US 2017/0246270
Methods of Constructing Antibody Fusions and Compositions Thereof
Application: 61/845,280 →
Methods of Constructing Immunoglobulin Beta Strand Fusion Proteins and Compositions Thereof
Application: 61/845,287 →
Methods of Constructing Immunoglobulin Fusion Proteins and Compositions Thereof
Application: 61/925,904 →
Immunoglobulin Fusion Proteins and Compositions Thereof
Application: 62/017,713 →
Chimeric Antigen Receptor T Cell Peptide Switches and Uses Thereof
Application: 62/009,054 →
Methods of Constructing Constant Region Antibody Fusion Proteins and Compositions Thereof
Application: 62/030,514 →
Constant Region Antibody Fusion Proteins and Compositions Thereof
Application: 62/064,199 →
Lipid Conjugates and Compositions Thereof
Application: 61/877,799 →
Peptide Lipid Conjugates, Stapled Peptide Lipid Conjugates, and Compositions Thereof
Application: 61/917,816 →
Modified Therapeutic Agents, Stapled Peptide Lipid Conjugates, and Compositions Thereof
Application: 16/000,829 →
Publication: US 2018/0344812
Small Molecule Inhibitors of Fibrosis
Application: 62/090,267 →
Small Molecule Inhibitors of Fibrosis
Application: 62/117,846 →
Methods of Constructing Amino Terminal Immunoglobulin Fusion Proteins and Compositions Thereof
Application: 62/030,526 →
Amino Terminal Immunoglobulin Fusion Proteins and Compositions Thereof
Application: 62/064,186 →
Optimized Chimeric Receptor T Cell Switches and Uses Thereof
Application: 62/148,070 →
Chimeric Receptor T Cell Switches and Uses Thereof
Application: 62/253,465 →
Agonists of Stimulator of Interferon Genes STING
Application: 62/633,409 →
Oxyntomodulin Analogs as GLP1R/GCGR Dual Agonists
Application: 62/248,866 →
Oxyntomodulin Analogs and Methods of Making and Using Same
Patent: 9,931,379 →
Application: 15/451,503 →
Publication: US 2017/0196940
Compounds for Treatment of Cystic Fibrosis
Application: 61/842,300 →
Compounds for Treatment of Cystic Fibrosis
Application: 61/969,737 →
Modified Therapeutic Agents and Compositions Thereof
Application: 62/134,939 →
Methods for Treating Viral Infections
Application: 62/141,763 →
Liver X Receptor Agonists and Uses Thereof
Application: 62/158,726 →
Liver X Receptor Agonists and Uses Thereof
Application: 15/147,863 →
Publication: US 2016/0324981
Modified Therapeutic Agents and Compositions Thereof
Application: 62/180,856 →
MST1 Inhibitors
Application: 62/184,813 →
Auristatin-Antibody Conjugates and Uses Thereof
Application: 62/192,768 →
Auristatin-Antibody Conjugates and Uses Thereof
Application: 15/210,729 →
Publication: US 2017/0014524
Insulin Immunoglobulin Fusion Proteins
Application: 62/214,605 →
Lpa Modulators for Brown Fat Differentiation
Application: 62/204,120 →
Lpa Receptor Modulators for Brown Fat Differentiation
Application: 15/234,994 →
Publication: US 2017/0042915
Methods of Constructing Immunoglobulin Fusion Proteins and Compositions Thereof
Application: 62/265,344 →
Humanized Anti-CD3 Antibodies, Conjugates and Uses Thereof
Application: 62/291,143 →
Antimalarial Compositions and Uses Thereof
Application: 62/352,455 →
Peptide Conjugates and Uses Thereof
Application: 62/342,720 →
Methods and Compositions for Preventing Vector-Borne Disease Transmission
Application: 62/415,287 →
SWITCHABLE NON-scFv CHIMERIC RECEPTOR T CELLS AND USES THEREOF
Application: 62/138,901 →
Optimized Chimeric Receptor Cell Switches and Uses Thereof
Application: 62/148,063 →
Chimeric Receptor T Cell Switches and Uses Thereof
Application: 62/253,467 →
Compounds for Treatment of Drug Resistant and Persistent Tuberculosis
Bovine Fusion Antibodies
Targeting Agent Antibody Conjugates and Uses Thereof
Bispecific Antibodies and Uses Thereof
Compounds and Methods for Inducing Chondrogenesis
Small Molecule Inhibitors of Fibrosis
Chimeric Antigen Receptor T Cell Switches and Uses Thereof
Peptidic Chimeric Antigen Receptor T Cell Switches and Uses Thereof
Immunoglobulin Fusion Proteins and Compositions Thereof
Coiled Coil Immunoglobulin Fusion Proteins and Compositions Thereof
Constant Region Antibody Fusion Proteins and Compositions Thereof
Modified Therapeutic Agents and Compositions Thereof
Modified Therapeutic Agents, Stapled Peptide Lipid Conjugates, and Compositions Thereof
Small Molecule Inhibitors of Fibrosis
Methods of Constructing Amino Terminal Immunoglobulin Fusion Proteins and Compositions Thereof
Chimeric Receptor T Cell Switches for HER2
Optimized Chimeric Receptor T Cell Switches and Uses Thereof
Oxyntomodulin Analogs and Methods of Making and Using Same
Compounds for Treatment of Cystic Fibrosis
Lung Localized Inhimitors of Alpha (V) Beta 6
Elastase Inhibitors
Compounds for Treatment of Cystic Fibrosis
Methods of Antibiotic Treatment with Metal-Thiolate Complexes
Modified Therapeutic Agents and Compositions Thereof
Methods for Treating Viral Infections
Modified Therapeutic Agents and Compositions Thereof
Composition and Methods for Inhibiting Mammalian Sterile 20-Like Kinase 1
Insulin Immunoglobulin Fusion Proteins
Relaxin Immunoglobulin Fusion Proteins and Methods of Use
Humanized Anti-CD3 Antibodies, Conjugates and Uses Thereof
Antimalarial Compositions and Uses Thereof
KV1.3 Channel Blocking Peptides and Uses Thereof
Methods and Compositions for Preventing Vector-Borne Disease Transmission
Compositions and Methods for Treating Drug-Resistant Bacteria
Methods for Inducing Chondrogenesis
Engineered Cell Surface Proteins and Uses Thereof
Switchable Non-Scfv Chimeric Receptors, Switches, and Uses Thereof
Optimized Pne-Based Chimeric Receptor T Cell Switches and Uses Thereof
Chimeric Antigen Receptor Effector Cell Switches with Humanized Targeting Moieties and/or Optimized Chimeric Antigen Receptor Interacting Domains and Uses Thereof
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 15, 2013
From: ZHANG, YONG; WANG, FENG; SCHULTZ, PETER G.
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 030797/0120 →
Assignment of Assignor's Interest Jul 15, 2013
From: ZHANG, YONG; WANG, FENG; SCHULTZ, PETER G.
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 030797/0033 →
Assignment of Assignor's Interest Jan 8, 2014
From: WANG, FENG; ZHANG, YONG; SCHULTZ, PETER
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 031921/0797 →
Assignment of Assignor's Interest Jan 8, 2014
From: WANG, FENG; ZHANG, YONG; SCHULTZ, PETER
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 031921/0302 →
Assignment of Assignor's Interest Jan 9, 2014
From: THE SCRIPPS RESEARCH INSTITUTE
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 031932/0934 →
Corrective Assignment to Correct the Execution Date of the Assignor Previously Entered as January 9, 2013 Previously Recorded on Reel 031932 Frame 0934. Assignor(S) Hereby Confirms the the Correct Execution Date of the Assignor Is January 9, 2014. Jan 13, 2014
From: THE SCRIPPS RESEARCH INSTITUTE
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 031997/0797 →
Assignment of Assignor's Interest Feb 4, 2014
From: WANG, FENG; ZHANG, YONG; SCHULTZ, PETER G.
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032130/0177 →
Assignment of Assignor's Interest Feb 12, 2014
From: KIM, CHANHYUK; SCHULTZ, PETER G.
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032202/0292 →
Assignment of Assignor's Interest Feb 12, 2014
From: LAIRSON, LUKE; SCHULTZ, PETER G.; CHATTERJEE, ARNAB K.; YANG, BAIYUAN
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032202/0165 →
Assignment of Assignor's Interest Feb 12, 2014
From: WANG, FENG; SCHULTZ, PETER G.; WANG, JIANING; HALDER, RAJKUMAR
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 032202/0207 →
Assignment of Assignor's Interest Feb 12, 2014
From: LAIRSON, LUKE; SCHULTZ, PETER G.; BOLLONG, MICHAEL
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 032202/0157 →
Assignment of Assignor's Interest Feb 12, 2014
From: SHEN, WEIJUN; SCHULTZ, PETER G.
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032202/0199 →
Assignment of Assignor's Interest Feb 12, 2014
From: SCHULTZ, PETER G.; ZHU, SHOUTIAN; PAYETTE, JOSHUA
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 032201/0871 →
Assignment of Assignor's Interest Feb 12, 2014
From: SCHULTZ, PETER G.; CHATTERJEE, ARNAB K.; ZHU, SHOUTIAN; YOON, HONGCHUL
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032201/0859 →
Assignment of Assignor's Interest Feb 12, 2014
From: KIM, CHANHYUK; AXUP, JUN Y.; SCHULTZ, PETER G.
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 032202/0273 →
Assignment of Assignor's Interest Feb 12, 2014
From: SHEN, WEIJUN; SCHULTZ, PETER G.
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032201/0934 →
Assignment of Assignor's Interest Feb 12, 2014
From: CAO, YU; KIM, CHANHYUK; SCHULTZ, PETER G.; YOUNG, TRAVIS
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032202/0036 →
Assignment of Assignor's Interest Feb 12, 2014
From: CAO, YU; KIM, CHANHYUK; SCHULTZ, PETER G.; YOUNG, TRAVIS
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032202/0091 →
Assignment of Assignor's Interest Feb 14, 2014
From: CHATTERJEE, ARNAB K.; WANG, FENG; SCHULTZ, PETER G.; XU, CHUNPING
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032219/0565 →
Assignment of Assignor's Interest Feb 14, 2014
From: WANG, FENG; SCHULTZ, PETER G.; WANG, JIANING; HALDER, RAJKUMAR
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 032219/0594 →
Assignment of Assignor's Interest Feb 18, 2014
From: WANG, FENG; ZHANG, YONG; SCHULTZ, PETER G.
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032238/0587 →
Assignment of Assignor's Interest Feb 18, 2014
From: KIM, CHANHYUK; SCHULTZ, PETER G.
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032238/0589 →
Assignment of Assignor's Interest Feb 24, 2014
From: KIM, CHANHYUK; AXUP, JUN Y.; YUN, HWAYOUNG; SCHULTZ, PETER G.
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 032286/0214 →
Assignment of Assignor's Interest May 14, 2014
From: KANEKO, TAKUSHI
To: THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
Reel/Frame 032890/0609 →
Assignment of Assignor's Interest May 14, 2014
From: SCHULTZ, PETER G.; CHATTERJEE, ARNAB K.; ZHU, SHOUTIAN; YOON, HONGCHUL
To: THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
Reel/Frame 032890/0517 →